ANUHPHR91.70

Anuh Pharma Limited

· Pharma & Health
₹ CrorePeersAHCLWANBURYZIMLABBAJAJHCARETHEMISMEDLINCOLNVALIANTLABSIGACHIMcap ₹919 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity14.5211.6511.65
Return on Assets9.357.367.36
Return on Capital Employed15.9014.2114.21
Return on Invested Capital15.3912.7315.11
Margins
EBITDA Margin9.218.007.78
Operating Margin7.896.526.52
Incremental Operating Margin-1.66
Pretax Margin9.227.037.37
Net Income Margin7.165.325.43
FCF Margin2.59-1.41-1.41
Additional
Effective Tax Rate22.3824.3026.25
Dvd Payout Ratio26.4436.47
Sustainable Growth Rate10.687.4011.65
Incremental Operating Margin %-1.665.67
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.